CpG DNA inhibits CD4+CD25+ Treg suppression through direct MyD88-dependent costimulation of effector CD4+ T cells.
about
Breaking Free of Control: How Conventional T Cells Overcome Regulatory T Cell Suppression.Toll-Like Receptors in the Pathogenesis of Autoimmune DiseasesThe effects of TLR activation on T-cell development and differentiationTreg functional stability and its responsiveness to the microenvironmentOrigin and functions of pro-inflammatory cytokine producing Foxp3+ regulatory T cellsRegulatory T cells suppress natural killer cells during plasmid DNA vaccination in mice, blunting the CD8+ T cell immune response by the cytokine TGFbetaMicrobial control of regulatory and effector T cell responses in the gut.Mechanisms underlying blockade of allograft acceptance by TLR ligandsRegulatory T cells and Toll-like receptors: what is the missing link?Ubiquitous points of control over regulatory T cells.Distinct inflammatory signals have physiologically divergent effects on epigenetic regulation of Foxp3 expression and Treg function.NOD1 cooperates with TLR2 to enhance T cell receptor-mediated activation in CD8 T cells.Immunologic characterization suggests reduced alloimmunization in a murine model of thalassemia intermediaProfound tumor-specific Th2 bias in patients with malignant glioma.Suppressive oligodeoxynucleotides promote the generation of regulatory T cells by inhibiting STAT1 phosphorylation.Combined TLR7/8 and TLR9 ligands potentiate the activity of a Schistosoma japonicum DNA vaccine.Engagement of TLR2 reverses the suppressor function of conjunctiva CD4+CD25+ regulatory T cells and promotes herpes simplex virus epitope-specific CD4+CD25- effector T cell responses.Toll-like receptors (TLRs) in transplantationIntestinal microbiota: shaping local and systemic immune responses.Microbe-dendritic cell dialog controls regulatory T-cell fate.Sterile inflammation - do innate lymphoid cell subsets play a role?T cell expression of MyD88 is required for resistance to Toxoplasma gondii.Sex differences in autoimmune disease from a pathological perspectiveProtective cancer immunotherapy: what can the innate immune system contribute?Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihydroxyvitamin D3 abrogates regulatory function.Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses.The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease.Inhibition of CD4+CD25+ regulatory T cell function and conversion into Th1-like effectors by a Toll-like receptor-activated dendritic cell vaccine.Inoculation of killed Leishmania major into immune mice rapidly disrupts immunity to a secondary challenge via IL-10-mediated process.Regulatory T cells overturned: the effectors fight back.CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1-Sj26GST.Toll-like receptor 9 agonist enhances anti-tumor immunity and inhibits tumor-associated immunosuppressive cells numbers in a mouse cervical cancer model following recombinant lipoprotein therapyImmune adjuvants in early life: targeting the innate immune system to overcome impaired adaptive response.Functions of invariant NK T cells are modulated by TLR ligands and IFN-α.Microbial infection-induced expansion of effector T cells overcomes the suppressive effects of regulatory T cells via an IL-2 deprivation mechanism.Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis.Signaling through the adaptor molecule MyD88 in CD4+ T cells is required to overcome suppression by regulatory T cells.The contribution of direct TLR signaling to T cell responses.Signaling through TLR7 enhances the immunosuppressive activity of murine CD4+CD25+ T regulatory cells.The adjuvant effect of TLR agonists on CD4(+) effector T cells is under the indirect control of regulatory T cells.
P2860
Q26744624-FA8F2170-F645-4EDB-AD78-6A43AEB05C24Q26770257-C7ECDDDE-03B5-4C7C-BA17-9A81AC6A4393Q27001581-0AAE4C72-0D0D-48A8-B736-CD3A961CAB75Q27008946-508899B1-F4BB-407A-8920-4B9D039F10D7Q28081922-A89E672F-948E-4394-87BC-B9B1B13B0390Q28475223-0BF6B4B1-A121-4E3E-8BC1-C6D79E449136Q33699119-6D8E18AE-799A-4134-85E7-8F842C37664FQ33732481-2B4CE7BE-46C8-48C1-9433-A8C9FDD8C4F8Q33798158-79A2ED87-66D0-4F5A-9B11-3D84656A9B88Q33850593-E0537B83-D40E-4462-9C5C-4DD3F73CAFABQ34158278-5DCA647A-577D-4497-9AE9-6502794AF93EQ34359613-3C2605E0-627B-4339-BE02-05E8EF72B024Q34459335-10786E65-B864-4FE6-A44C-C5ABF1AB9765Q34491734-EB7398B8-8D3E-46A9-BF8C-908903DCE928Q34602996-28EBDFB3-69C8-46AD-9A29-8F84D9B85661Q34675128-DCAD5EB9-D0BE-46D6-A8B0-52DEE8314510Q35027578-F74085BD-2F5F-414B-85B3-CAA64CE81352Q35581147-614062B8-4B5F-4B19-A938-D597C00EDA04Q35799746-4B33BE8F-BA77-42E9-8658-F7ABBB170829Q36115730-0C206525-5AB3-4F95-8B0C-63F5BA3CB364Q36144350-B5C8F862-F688-4CC7-A495-3BF885826E80Q36499083-984BC662-B9C4-4144-95FB-5F5191D4F580Q36855667-6992C6F7-3C90-4F84-AF14-324C3B44A6F7Q37032632-A8BE09E3-E398-40D7-9AB8-DE71612386C5Q37073695-0EFB57BC-150D-4936-BEFD-B965936B56FBQ37267529-CF53ADE3-1012-4643-9DE9-9F740879FD47Q37272092-3157FB10-7CF7-4953-BB57-1D4E2415D7CEQ37297514-7D553ECB-B1C5-47E7-B629-278CD22D95F0Q37310681-DC73FF65-67B3-4E8D-9F3A-601574174C6CQ37412624-5EEC927D-0EEC-4913-80D5-E7E3FBFECAE4Q37565174-BFF8811C-5443-4A99-8CE2-42FF40F33B3AQ37724053-503E846E-170B-4A0B-87C6-170C538253E6Q37773306-6FF26CBF-55FF-4BC6-BE26-81A27327451DQ38984210-D4EF9127-3D2A-4D29-A824-A26D63BD8D91Q40227012-10AE3206-5A0E-4A84-AEA1-C7E0349008E2Q40974392-714AC8F4-C306-4488-AA2D-CB879171267EQ41155531-5EFBE719-BFF1-4BA9-8069-81B83E848DD2Q41585090-4297F350-F2D1-4E99-AB8F-27B2C25BC1FFQ43258134-DA2A02EB-BF98-4592-AE1F-EBACF3865DFCQ50521448-D0920EAD-27CA-46A7-A4C3-85C3614E2DB8
P2860
CpG DNA inhibits CD4+CD25+ Treg suppression through direct MyD88-dependent costimulation of effector CD4+ T cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
CpG DNA inhibits CD4+CD25+ Tre ...... tion of effector CD4+ T cells.
@ast
CpG DNA inhibits CD4+CD25+ Tre ...... tion of effector CD4+ T cells.
@en
type
label
CpG DNA inhibits CD4+CD25+ Tre ...... tion of effector CD4+ T cells.
@ast
CpG DNA inhibits CD4+CD25+ Tre ...... tion of effector CD4+ T cells.
@en
prefLabel
CpG DNA inhibits CD4+CD25+ Tre ...... tion of effector CD4+ T cells.
@ast
CpG DNA inhibits CD4+CD25+ Tre ...... tion of effector CD4+ T cells.
@en
P2093
P2860
P1433
P1476
CpG DNA inhibits CD4+CD25+ Tre ...... tion of effector CD4+ T cells.
@en
P2093
Andrew E Gelman
David F LaRosa
Jidong Zhang
Laurence A Turka
P2860
P304
P356
10.1016/J.IMLET.2006.12.007
P577
2007-01-18T00:00:00Z